Navigation Links
Lab test for allergy scoops national
Date:11/26/2008

ing the symptoms of allergy. Cellular activation can then be analysed to discover which of the allergens are prompting the release of histamine and other chemicals indicative of allergic reaction in the patient's blood.

Dr Marcos Alcocer, a lecturer in the School of Biosciences, said: "The whole idea is to trace what we call our immunological profile, the finger print of our immune system which tells us how we react to the things which we are surrounded by.

"Our technology is one step towards the ultimate goal of being able to have a full in-vitro diagnostic test for allergy. What we have to do now is examine the results of our test further and then assess how well it works compared to the gold standard techniques currently used for diagnosis. We will then be in a very good position for commercialisation."

Researchers from The University of Nottingham were also highly commended in the Clinical Impact category of the Da Vinci Awards. A collaboration between Professor Ian Ellis in the University's School of Molecular Medical Sciences and colleagues at Nottingham Trent University and University Hospital Nottingham has led to the development of a breast cancer prognostic tool.

Nottingham Prognostic Index offers a personalised approach to medicine by classifying patients into groups according to their tumour biology, provides information about the patients' most probable survival outcome and guides clinicians in the most appropriate form of treatment.

The tool should reduce the incidence of over-treatment and minimise the harmful side-effects for patients and is due to be commercialised by a spin-out company Nottingham Prognostics.

Anna Seddon, Manager of the Da Vinci Network, said: "The excellent response to the Da Vinci Awards reinforces the importance of building interdisciplinary and inter-institutional collaboration to address critical issues in healthcare. The quality of applicants reflects the wealth of activi
'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.acuk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Expert recommends town councils to design low-allergy impact green spaces
2. Munich researchers discover key allergy gene
3. NIAID announces grants to stimulate food allergy research
4. NIH selects LIAI for major study on allergy molecular causes and possible treatments
5. RSC Project Prospect scoops prestigious award
6. Halas wins high-profile national security award
7. New national survey says public reveres bison
8. National and international doctoral training
9. International team discovers gene associated with epilepsy
10. PNNL leadership in carbon sequestration featured at international conference
11. Engineer to present leak-proof method for carbon dioxide storage at international conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/24/2015)... , June 24, 2015 Biometry ... with emerging biometric password solution one face in. ... one face in, entering the ... ground-breaking and affordable multifactor-authentication biometric answer to the ... technology, provided in partnership with KeyLemon, one face ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... preserve grapes could help prevent allergies and boost healthy compounds ... Industry, the magazine of the SCI. The same technique could ... without the added sulphites that can cause asthma and other ... in storage for months and are usually treated with sulphur ...
... Researchers at Columbia University’s Mailman School of Public Health ... cancer. Using DNA isolated from serum samples as ... tumor suppressor genes that have been associated with the ... to prospectively examine potential biomarkers for early detection of ...
... normally used to treat insomnia, temporarily improved brain function ... in which the person is alert but cannot speak ... and eat without assistance after receiving the drug for ... the March 2007 issue of Annals of Neurology ( ...
Cached Biology News:Grape expectations for healthier wine 2Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer 2Insomnia drug can improve brain function 2
(Date:7/7/2015)...   Moleculera Labs today announced the ... the Oklahoma Center for the Advancement of Science ... and clinical validation of new diagnostic testing panels ... patients experiencing neuropsychiatric disorders such as depression, bipolar ... assist physicians in identifying the subset of patients ...
(Date:7/7/2015)... ... ... CSM, a leading clinical trial supply company, today announced that Michael Morse has ... in financial management and accounting, bringing over 20 years of experience in the biotechnology ... all financial areas of the company to both strengthen CSM’s financial strategy and meet ...
(Date:7/6/2015)... ... July 06, 2015 , ... A study by a multidisciplinary ... virulent fungi adapt through genetic modifications to fight back against the effects of ... weakened. These insights may provide clues to new ways to treat notoriously difficult-to-cure ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... and cheaper molecular diagnostic tests are key drivers of the global molecular diagnostics ... personalized medicine and the introduction of new companion diagnostic tests will increase demand ...
Breaking Biology Technology:Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3CSM Appoints Michael Morse as Vice President of Finance 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3
... INC. (Nasdaq: VION ) today announced that the ... 7.75% Convertible Senior Notes due,2012 (the "Notes"). The aggregate ... Company paid $2,260,416.67 in interest through the issuance of,shares ... in,2,539,200 shares of Common Stock, based on today,s closing ...
... Ltd. (NASDAQ: HCTL ), today announced unaudited results for ... Revenues for the first six months of 2007 were ... of 2006. The gross profit for the,first half of the ... in 2006. The net loss for such period was $(319) ...
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), ... Listings Qualifications Department informed the Company that the,market ... million for 10,consecutive days, which is the requirement ... to Marketplace Rule 4450(b)(1)(A). Nasdaq,also informed the Company ...
Cached Biology Technology:Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes 2Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes 3Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results 2Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results 3Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 2Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 3Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 4
streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
AedestaTM Animal Organ/Tissue Perfusion Soln....
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: